Tuesday 30 April 2013

FDA approves Raptor's drug for nephropathic cystinosis

WASHINGTON (Reuters) - The Food and Drug Administration has approved an experimental drug from Raptor Pharmaceutical Corp to treat a rare genetic disorder that can cause irreversible tissue damage, organ failure and premature death. Raptor's s...

Source: http://health.yahoo.net/news/s/nm/fda-approves-raptor-s-drug-for-nephropathic-cystinosis

for more info site website view

No comments:

Post a Comment

Note: only a member of this blog may post a comment.